Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Cancer Metastatic × Lycopene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 14 Male Urogenital Diseases 3 Prostatic Intraepithelial Neoplasia 2 Uremia 1 Prostatic Hyperplasia 1 Neoplasms 1 Disease Progression 1 Colorectal Cancer Metastatic 1 Carcinoma, Transitional Cell 1

Interventions

Bevacizumab 18 Capecitabine 15 Cetuximab 11 Oxaliplatin 10 Irinotecan 10 Fluorouracil 9 aflibercept 7 Leucovorin 7 Panitumumab 6 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Vemurafenib 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Ipilimumab 2 Drug Therapy 2 spartalizumab 1 raltitrexed 1 pembrolizumab 1 monoclonal antibody YYB-101 1 masitinib 1 irinotecan sucrosofate 1 folfirinox 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anisodamine 1 XELOX 1 Tyrosine Kinase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03167268 2021-09-09

PaSTo

Ospedale San Carlo Borromeo

Phase 2 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡